Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 1,992 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 1 Clear all

Conditions: Pancreatic Cancer
Interventions: RO70097890, nab-paclitaxel, gemcitabine; Drug
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cerebrovascular Accident
Interventions: FINGER I, FINGER II; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Irvine, California

Conditions: Pain, Chronic, Pain Syndrome, Psychological
Interventions: Promoting Resilience in Stress Management, Usual Care; Behavioral · Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Speech Sound Disorder
Interventions: Perceptual training, Production training; Behavioral
Lead sponsor: Montclair State University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Upper Montclair, New Jersey

Conditions: Prediabetic State, Type 2 Diabetes Mellitus With Oral Complications, Periodontal Pocket, Tooth Loss
Interventions: Enhanced intervention; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 30 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo, Testosterone, Buspirone hydrochloride; Drug
Lead sponsor: Emotional Brain NY Inc.; Industry
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 207 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 12
States / cities: San Diego, California • Bradenton, Florida • North Miami, Florida + 9 more

Conditions: Dementia Family Caregiver, Dementia, Medication Adherence
Interventions: Medication Collaboration Intervention; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Pancreatitis (AP)
Interventions: Lactated Ringer's, Lactated Ringers Stroke Volume Based Dosing; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Los Angeles, California • Columbus, Ohio

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Dex-methylphenidate hydrochloride extended-release (Focalin XR), Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 5
States / cities: Little Rock, Arkansas • Winter Park, Florida • Las Vegas, Nevada + 2 more

Conditions: Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8, Stage IIB Colorectal Cancer AJCC v8, Stage IIC Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
Interventions: Dietary Intervention; Dietary Supplement
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Parkinson Disease
Interventions: taVNS, Exercise; Device · Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 35 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Obesity, Diet, Healthy
Interventions: Snackability app, Control group; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Mantle Cell Lymphoma, Refractory Lymphoma
Interventions: Acalabrutinib, Venetoclax, Obinutuzumab; Drug
Lead sponsor: Austin I Kim; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 3
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Borderline Personality Disorder, Emotional Problem
Interventions: Dialectical Behavior Therapy Skills; Behavioral
Lead sponsor: University of Oregon; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Traumatic Brain Injury
Interventions: Yoga-based physical therapy group, Seated Rest, Conventional Physical Therapy; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 99 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mental Disorder, Physical Illness
Interventions: Integrated Care, Peer Navigation; Behavioral
Lead sponsor: Illinois Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: COVID-19
Interventions: Hydroxychloroquine, Azithromycin, Zinc Sulfate, Doxycycline; Drug
Lead sponsor: St. Francis Hospital, New York; Other
Eligibility: 30 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Roslyn, New York

Conditions: Stress Disorders, Post Traumatic
Interventions: Mantram Repetition Program (MRP) plus Usual Care, Usual care consisting of medication and case management; Behavioral · Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Haemophilia A, Haemophilia B
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 1 Year to 21 Years · Male only
Enrollment: 563 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 22
States / cities: Los Angeles, California • Orange, California • San Diego, California + 19 more

Conditions: HIV Prevention
Interventions: SBCM-PrEP, CDC-PrEP; Behavioral
Lead sponsor: Hilary L Surratt, PhD; Other
Eligibility: 18 Years to 99 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Heart Failure, Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III
Interventions: PP-MI Intervention, MI-alone Intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: RSV Infection
Interventions: Nirsevimab; Drug
Lead sponsor: Yale University; Other
Eligibility: Up to 12 Months
Enrollment: 3,750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo, 0.5 mgTestosterone + 10 mg Buspirone; Drug
Lead sponsor: Emotional Brain NY Inc.; Industry
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 10
States / cities: San Diego, California • Bradenton, Florida • Orlando, Florida + 7 more

Conditions: Overweight, Obesity
Interventions: Primary Care Practice Changes; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 2 Years to 12 Years
Enrollment: 3,765 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Fitchburg, Massachusetts • New Bedford, Massachusetts

Search by objective public record fields.

Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma

FINGER Robot Therapy Study

Resilience Coaching for Adolescents With Chronic Musculoskeletal Pain

Auditory-Perceptual Training Via Telepractice

Undiagnosed Diabetes in a Dental Setting

Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems

Medication Collaboration Feasibility Study

Stroke Volume-based Fluid Resuscitation in AP

A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

Diet Education Program for Stage I-IV Colorectal Cancer Survivors

Combining VNS With PT Interventions for Individuals With PD

Effectiveness of the Snackability Smartphone Application to Improve Quality of the Snack Intake, General Diet Quality, and Weight Among College Students

Avo In R/R And Previously Untreated MCL

Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder

The Impact of Yoga-based Physical Therapy for Individuals With Traumatic Brain Injury

Peer Navigators for the Health and Wellness of People With Psychiatric Disabilities

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Mantram Repetition to Manage PTSD in Veterans

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky

Promoting Well-being and Health in Heart Failure

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder

Mass in Motion Kids in the Clinical Setting